The AACE Diabetes Guidelines
The 2013-AACE algorithm and consensus statement on diabetes[5] has been criticized with particular concerns about transparency, conflicts of interest, group composition, and the abundant use of personal judgment and experience instead of rigorous methodology.[6] Despite all these concerns, the ultimate feeling is that the major concern relates to the financial ties. Most panel members, including the chair, of the diabetes AACE guidelines had financial conflicts of interest,[6] and many of the financial associations were with companies that sell diabetes medications that figure prominently in the algorithm and consensus statement.
Cardiovasc Diabetol. 2014;13(66) © 2014 BioMed Central, Ltd.